eMedicine Specialties > Urology > Cancer, Wilms Tumor and Neuroblastoma

Neuroblastoma: Multimedia

Author: Byron D Joyner, MD, Associate Professor, Department of Urology, University of Washington School of Medicine; Consulting Staff, Program Director, Department of Surgery, Division of Pediatric Urology, Children's Hospital and Regional Medical Center
Coauthor(s): Natalya Lopushnyan, Yale University School of Medicine
Contributor Information and Disclosures

Updated: Dec 4, 2007

Multimedia

CT scan in a 2-week-old boy noted to have an abdo...Media file 1: CT scan in a 2-week-old boy noted to have an abdominal mass on a prenatal sonogram. This postnatal abdominal CT scan revealed a left suprarenal mass with mass effect of the spleen.
CT scan in a 2-week-old boy noted to have an abdo...

CT scan in a 2-week-old boy noted to have an abdominal mass on a prenatal sonogram. This postnatal abdominal CT scan revealed a left suprarenal mass with mass effect of the spleen.

Abdominal CT scan in a 2-week-old boy noted to ha...Media file 2: Abdominal CT scan in a 2-week-old boy noted to have an abdominal mass on a prenatal sonogram. A postnatal abdominal CT scan revealed a left suprarenal mass with mass effect of the spleen (see Image 1). This abdominal CT scan represents a more caudal view than Image 1. Note the very large left mass with central necrosis. The mass effect of the spleen is apparent.
Abdominal CT scan in a 2-week-old boy noted to ha...

Abdominal CT scan in a 2-week-old boy noted to have an abdominal mass on a prenatal sonogram. A postnatal abdominal CT scan revealed a left suprarenal mass with mass effect of the spleen (see Image 1). This abdominal CT scan represents a more caudal view than Image 1. Note the very large left mass with central necrosis. The mass effect of the spleen is apparent.

A 2-week-old boy is noted to have an abdominal ma...Media file 3: A 2-week-old boy is noted to have an abdominal mass on prenatal ultrasound. A postnatal abdominal CT scan revealed a left suprarenal mass with mass effect of the spleen (see Image 1). A more caudal view than Image 1 revealed the very large left mass with central necrosis (see Image 2). This is a more caudal view of the CT scan than in Images 1 and 2. The left kidney comes into view, as it is inferiorly displaced and laterally rotated by the large superior neuroblastoma.
A 2-week-old boy is noted to have an abdominal ma...

A 2-week-old boy is noted to have an abdominal mass on prenatal ultrasound. A postnatal abdominal CT scan revealed a left suprarenal mass with mass effect of the spleen (see Image 1). A more caudal view than Image 1 revealed the very large left mass with central necrosis (see Image 2). This is a more caudal view of the CT scan than in Images 1 and 2. The left kidney comes into view, as it is inferiorly displaced and laterally rotated by the large superior neuroblastoma.

Bulky lymph nodes just medial to the left kidneyMedia file 4: Bulky lymph nodes just medial to the left kidney
Bulky lymph nodes just medial to the left kidney

Bulky lymph nodes just medial to the left kidney

Upper periorbital edema, proptosis, and ecchymosi...Media file 5: Upper periorbital edema, proptosis, and ecchymosis in the left eye in a 9-month-old girl.
Upper periorbital edema, proptosis, and ecchymosi...

Upper periorbital edema, proptosis, and ecchymosis in the left eye in a 9-month-old girl.

More on Neuroblastoma

Overview: Neuroblastoma
Workup: Neuroblastoma
Treatment: Neuroblastoma
Follow-up: Neuroblastoma
Multimedia: Neuroblastoma
References

References

  1. Virchow R. Hyperplasie der Zirbel und der Nebennieren. In: Die Krankhaften Geschwulste. Vol 2. 1864-65.

  2. Marchand F. Beitrage zur Kenntniss der normalen und pathologischen Anatomie der Glandula carotica und der Nebennieren. Festschrift fur Ruduloph. Vichows Arch. 1891;5:578.

  3. Herxheimer G. Ueber Turmoren des Nebennierenmarkes, insbesondere das Neuroblastoma sympaticum. Beitr Pathol Anat. 1914;57:112.

  4. Cushing H, Wolback SB. The transformation of a malignant paravertebral sympathicoblastoma into a benign ganglioneuoma. Am J Pathol. 1927;3:203.

  5. Everson TC, Cole WH. Spontaneous regression of neuroblastoma. In: Everson TC, Cole WH, eds. Spontaneous Regression of Cancer. Philadelphia, Pa: WB Saunders; 1966:88.

  6. Mason GA, Hart-Mercer J, Millar EJ, Strang LB, Wynne NA. Adrenaline-secreting neuroblastoma in an infant. Lancet. Aug 17 1957;273(6990):322-5. [Medline].

  7. Beckwith JB, Perrin EV. In situ neuroblastomas: A contribution to the natural history of neural crest tumors. Am J Pathol. Dec 1963;43:1089-104. [Medline].

  8. Knudson AG Jr, Strong LC. Mutation and cancer: neuroblastoma and pheochromocytoma. Am J Hum Genet. Sep 1972;24(5):514-32. [Medline].

  9. Nitschke R, Smith EI, Shochat S, et al. Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study. J Clin Oncol. Aug 1988;6(8):1271-9. [Medline].

  10. Shimada H, Chatten J, Newton WA Jr, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst. Aug 1984;73(2):405-16. [Medline].

  11. Bostrom B, Nesbit ME Jr, Brunning RD. The value of bone marrow trephine biopsy in the diagnosis of metastatic neuroblastoma. Am J Pediatr Hematol Oncol. Fall 1985;7(3):303-5. [Medline].

  12. Brodeur GM, Castleberry RP. Neuroblastoma. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Vol 1. Philadelphia, Pa: Lippincott, Williams & Wilkins; 1993:739-67.

  13. Brodeur GM, Green AA, Hayes FA. Cytogenetic studies of primary human neuroblastomas. Prog Cancer Res Ther. 1980;12:73.

  14. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. Aug 1993;11(8):1466-77. [Medline].

  15. Brodeur GM, Seeger RC, Barrett A, et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol. Dec 1988;6(12):1874-81. [Medline].

  16. Connolly AM, Pestronk A, Mehta S, et al. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues. J Pediatr. Jun 1997;130(6):878-84. [Medline].

  17. Grosfeld JL. Neuroblastoma. In: Pediatric Surgery. Vol 1. 1998:405-19.

  18. Homsy YL, Austin PF. Neuroblastoma. In: Graham SD Jr, ed. Glenn's Urologic Surgery. 5th ed. Philadelphia, Pa: Lippincott-Raven; 1998:687-90.

  19. Howman-Giles R, Shaw PJ, Uren RF, Chung DK. Neuroblastoma and other neuroendocrine tumors. Semin Nucl Med. Jul 2007;37(4):286-302. [Medline].

  20. Kim S, Chung DH. Pediatric solid malignancies: neuroblastoma and Wilms' tumor. Surg Clin North Am. Apr 2006;86(2):469-87, xi. [Medline].

  21. Kushner BH, Helson L. Coordinated use of sequentially escalated cyclophosphamide and cell- cycle-specific chemotherapy (N4SE protocol) for advanced neuroblastoma: experience with 100 patients. J Clin Oncol. Nov 1987;5(11):1746-51. [Medline].

  22. Look AT, Hayes FA, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol. Apr 1991;9(4):581-91. [Medline].

  23. Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet. Jun 23 2007;369(9579):2106-20. [Medline].

  24. Matthay KK, Sather HN, Seeger RC, et al. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol. Feb 1989;7(2):236-44. [Medline].

  25. Mora J, Cheung NK, Kushner BH, et al. Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p. J Mol Diagn. Feb 2000;2(1):37-46. [Medline].

  26. Roberts S, Creamer K, Shoupe B, et al. Unique management of stage 4S neuroblastoma complicated by massive hepatomegaly: case report and review of the literature. J Pediatr Hematol Oncol. Feb 2002;24(2):142-4. [Medline].

  27. Ross JA, Davies SM. Screening for neuroblastoma: progress and pitfalls. Cancer Epidemiol Biomarkers Prev. Feb 1999;8(2):189-94. [Medline].

  28. Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Semin Nucl Med. Jul 2006;36(3):228-47. [Medline].

  29. Russell DS, Rubenstein LJ. Tumors of peripheral neuroblasts and ganglion cells. In: Pathology of Tumors of the Central Nervous System. Baltimore, Md: Williams & Wilkins; 1989:900.

  30. Russo C, Cohn SL, Petruzzi MJ, de Alarcon PA. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group. Med Pediatr Oncol. Apr 1997;28(4):284-8. [Medline].

  31. Tonini GP, Boni L, Pession A, et al. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children. J Clin Oncol. Jan 1997;15(1):85-93. [Medline].

  32. Weinstein JL, Katzenstein HM, Cohn SL. Advances in the diagnosis and treatment of neuroblastoma. Oncologist. 2003;8(3):278-92. [Medline].

  33. Young JL Jr, Ries LG, Silverberg E, et al. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer. Jul 15 1986;58(2 Suppl):598-602. [Medline].

Further Reading

Keywords

neuroblastoma, great mimicker, the great mimicker, intra-abdominal malignancy, extracranial solid tumor, Ewing sarcoma, non-Hodgkin lymphoma, neuroectodermal tumors, undifferentiated soft tissue sarcoma, rhabdomyosarcoma, glioma, sympathetic ganglia, ganglioneuroma, sympathoblastoma, ganglioneuroma, neurocristopathy, ganglioneuroblastoma, metastatic neuroblastoma, localized neuroblastoma, disseminated neuroblastoma, stage 4S neuroblastoma, Pepper syndrome, “blueberry muffin” babies, “blueberry muffin” baby, Hutchinson syndrome, Kerner-Morrison syndrome, Wilms tumor, congenital mesoblastic nephroma, primitive neuroblasts, neuropil, Homer-Wright pseudorosettes, Opsoclonus-myoclonus syndrome

Contributor Information and Disclosures

Author

Byron D Joyner, MD, Associate Professor, Department of Urology, University of Washington School of Medicine; Consulting Staff, Program Director, Department of Surgery, Division of Pediatric Urology, Children's Hospital and Regional Medical Center
Byron D Joyner, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Surgeons, American Urological Association, Association of Military Surgeons of the US, Massachusetts Medical Society, Society of University Urologists, Society of Urology Chairpersons and Program Directors, and Washington State Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Natalya Lopushnyan, Yale University School of Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

CME Editor

J Stuart Wolf Jr, MD, FACS, David A Bloom Professor of Urology, Director of Division of Minimally Invasive Urology, Department of Urology, University of Michigan
J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology
Disclosure: Terumo Corporation Consulting fee Consulting; Omeros Corporation Consulting fee Consulting

Chief Editor

Allen R Wyler, MD, Former Medical Director, Northstar Neuroscience, Inc
Allen R Wyler, MD is a member of the following medical societies: American Academy of Neurological and Orthopaedic Surgeons, American Association of Neurological Surgeons, and Society of Neurological Surgeons
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.